Form 4: IDEXX Laboratories Director Reports Stock Transactions

Director Sophie V. Vandebroek reports transactions involving IDEXX Laboratories stock, including the vesting of restricted stock units and the grant of stock options.

Summary

• Sophie V. Vandebroek, a director of IDEXX Laboratories, reported transactions on May 6, 2025, involving the company's common stock.
• These transactions include the vesting of 262 restricted stock units (RSUs) and the disposition of 262 shares of common stock.
• Vandebroek also acquired 600 non-qualified stock options on May 7, 2025, exercisable beginning May 7, 2025, and expiring on May 6, 2035.
• Additionally, 257 restricted stock units were acquired on May 7, 2025.
• Following these transactions, Vandebroek directly owns 0 shares of common stock and indirectly owns 8,173 shares through the Sophie V. Vandebroek Revocable Trust.
• She also directly owns 600 non-qualified stock options and 257 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of company directors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership of a director.

Key Dates

Keywords

IDEXX Laboratories, Director, Stock Transactions, Form 4, Restricted Stock Units, Stock Options, Beneficial Ownership